Does expenditure on pharmaceuticals give good value for money?: current evidence and policy implications
- 30 November 1993
- journal article
- review article
- Published by Elsevier in Health Policy
- Vol. 26 (1) , 55-75
- https://doi.org/10.1016/0168-8510(93)90078-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Health Economics in Primary Care in the UKPharmacoEconomics, 1993
- Cost-utility in practice: A policy maker's guide to the state of the artHealth Policy, 1992
- Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?Health Economics, 1992
- Why a Journal of Pharmacoeconomics?PharmacoEconomics, 1992
- Cost‐benefit analysis of non‐pharmacological treatment of hypertensionJournal of Internal Medicine, 1991
- Cost-utility analysis of thrombolytic therapyEuropean Heart Journal, 1991
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991
- Cost-effectiveness of prophylaxis in total hip replacementThe American Journal of Surgery, 1991
- Economic evaluation in health care: Is there a role for cost-benefit analysis?Health Policy, 1991
- Cost-effectiveness Analysis of Periodontal Disease ControlJournal of Dental Research, 1987